PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-2.07%
Negative net income growth while ORCL stands at 52.01%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
14.29%
D&A growth well above ORCL's 15.13%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
47.57%
Well above ORCL's 91.38% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-385.79%
Negative yoy SBC while ORCL is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-307.68%
Both reduce yoy usage, with ORCL at -496.21%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-211.85%
AR is negative yoy while ORCL is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22994.12%
Both reduce yoy usage, with ORCL at -496.21%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
968.62%
Well above ORCL's 293.02%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-42.32%
Negative yoy CFO while ORCL is 27.22%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-60.47%
Both yoy lines negative, with ORCL at -23.08%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-1411.59%
Both yoy lines negative, with ORCL at -14069.39%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-48.20%
Both yoy lines negative, with ORCL at -19.03%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
137.68%
Proceeds from sales/maturities above 1.5x ORCL's 38.92%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-55.34%
Both yoy lines negative, with ORCL at -100.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
35.35%
We have mild expansions while ORCL is negative at -1955.97%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-1312.31%
Both yoy lines negative, with ORCL at -33.97%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-247.26%
Both yoy lines negative, with ORCL at -1.21%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.